Synapsin-3: A Protein Target for Neurological Disorders (G8224)

Target Name: SYN3

NCBI ID: G8224

Synapsin-3: A Protein Target for Neurological Disorders

Synapsin-3 (ISOform IIIg) is a protein that is expressed in the nervous system and has been shown to play a role in the transmission of neural signals. Mutations in the Synapsin-3 gene have been linked to a variety of neurological and psychiatric disorders , including Alzheimer's disease, Parkinson's disease, and schizophrenia. As a result, Synapsin-3 has become a promising drug target for researchers.

Synapsin-3 is a transmembrane protein that is composed of four subunits. It is expressed in the brain and plays a critical role in the transmission of neural signals from the sensory cortices to the motor cortices. Synapsin-3 is composed of two transmembrane domains, a N-terminus domain, and a C-terminus domain. The N-terminus domain is responsible for the protein's ability to interact with intracellular signaling molecules, while the C-terminus domain is responsible for the protein's ability to interact with other proteins.

Synapsin-3 has been shown to play a role in a variety of neural processes, including the transmission of sensory information, the regulation of neurotransmitter release, and the modulation of neural activity. One of the most interesting functions of Synapsin-3 is its role in the regulation of synaptic transmission. Synapsin-3 plays a crucial role in transmitting information between neurons.

Mutations in Synapsin-3 can lead to neuronal apoptosis, damage synaptic structure, and then lead to impaired neurotransmission function. In addition, Synapsin-3 is also related to neuronal apoptosis. Apoptosis is an important neurobiological process and is of great significance for neuronal damage and treatment.

Synapsin-3 is considered a potential drug target due to its important role in neurotransmission. Researchers are exploring the use of small molecules, antibodies, and other biochemical approaches to target Synapsin-3 and its associated signaling pathways in order to treat a variety of neurological and psychiatric disorders.

In addition to its potential therapeutic applications, Synapsin-3 also has significant potential as a biomarker for the diagnosis and monitoring of neurological disorders. The loss of Synapsin-3 has been observed in a variety of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Therefore, the level of Synapsin-3 expression in a patient's brain or urine can be a valuable diagnostic or monitoring tool for these disorders.

In conclusion, Synapsin-3 is a protein that plays a critical role in the transmission of neural signals in the nervous system. Its mutations have been linked to a variety of neurological and psychiatric disorders, making it an attractive drug target for researchers. Additionally, Synapsin-3 has significant potential as a biomarker for the diagnosis and monitoring of these disorders. Further research is needed to fully understand the role of Synapsin-3 in neural processes and its potential as a therapeutic agent.

Protein Name: Synapsin III

Functions: May be involved in the regulation of neurotransmitter release and synaptogenesis

More Common Targets